D3Up

Quick links to important sections

D3Up

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of D3Up

Property Description
Active ingredient Colecalciferol (Vitamin D3)
Form Tablet, Softgel Capsule, Oral Solution, Granules (Sachet)
Pharmacological class Vitamin D Analog
General use Supporting bone and mineral health
Origin Secosteroid Pro-hormone

What Type of Medicine is D3Up (Colecalciferol)?

D3Up is a pharmaceutical preparation containing Colecalciferol as the active constituent, which is officially categorized as a Vitamin D analog and a crucial fat-soluble compound. Colecalciferol is widely recognized as Vitamin D3. The substance functions as a secosteroid pro-hormone, meaning the body must metabolically convert it into the biologically potent steroid hormone calcitriol through two hydroxylation steps primarily occurring in the liver and kidneys. This vital conversion pathway occurs in humans.

Composition and Available Pharmaceutical Forms

The composition of D3Up relies solely on the Colecalciferol molecule as its single active ingredient. Due to the substance's fat-soluble nature, the medicine is formulated with an appropriate base, such as a lipid-based carrier in liquid forms, to facilitate its absorption following oral administration. D3Up is supplied in several pharmaceutical preparations, including the solid tablet and softgel capsule, as well as the liquid oral solution and powder granules provided in a sachet. This variety in dosage form ensures flexible delivery to support adherence across different patient groups, such as the elderly or those with swallowing difficulties.

General Purpose and Physiological Role

The primary purpose of D3Up is to maintain adequate systemic levels of Colecalciferol to regulate the body’s essential balance of calcium and phosphorus. The activation process allows it to directly facilitate the intestinal absorption of these minerals, which are foundational components of the skeleton. Vitamin D promotes calcium absorption in the gut and is necessary for maintaining adequate serum calcium and phosphate concentrations. Therefore, this preparation ensures the body has the necessary precursors to support bone mineralization and the long-term structural integrity of the skeletal system. A typical use scenario involves providing nutritional support for individuals with limited sun exposure.

What side effects are possible with D3Up?

Possible Side Effects and Safety Information

The safety profile of Colecalciferol (D3Up) is primarily related to the risk of excessive intake, which can lead to high levels of calcium in the blood (hypercalcaemia) and urine (hypercalciuria). The information below is based strictly on government regulatory documents.


Documented Adverse Reactions

Adverse reactions are classified by how often they occur:

System Organ Class Frequency Category Adverse Reaction
Metabolism and Nutrition Uncommon Hypercalcaemia, Hypercalciuria
Skin and Subcutaneous Tissue Rare Pruritus (itching), Rash, Urticaria (hives)
Gastrointestinal Disorders Not Known Constipation, Nausea, Abdominal pain, Diarrhea

Serious Safety Risks and Contraindications

Serious Adverse Reactions

Chronic excessive dosing can result in Hypervitaminosis D (toxicity). Serious consequences of this state are primarily due to severe hypercalcaemia, which can lead to soft tissue calcification (e.g., in blood vessels or kidneys) and potentially result in irreversible renal insufficiency and the formation of kidney stones (renal calculi).

Safety-Related Restrictions (Contraindications)

D3Up must not be used if the patient has certain pre-existing conditions, including Hypercalcaemia, Hypercalciuria, known Hypervitaminosis D, hypersensitivity to the drug, or a history of calcium-containing renal calculi.


Special Population Safety Notes

Specific caution is required for individuals with renal impairment (kidney function issues) and those with sarcoidosis. In pregnancy and breast-feeding, use should not exceed recommended dietary allowances unless medically essential, and the infant's total exposure to Vitamin D must be considered.

Overdose and Emergency Response

Overdose is strictly defined by regulatory authorities as Hypervitaminosis D, which results in the primary toxic effect of Hypercalcaemia (elevated blood calcium). The regulatory profile specifies that chronic excessive intake may lead to this condition, with symptoms generally affecting multiple body systems.

Overdose Manifestations Severe / Life-Threatening Outcomes
Gastrointestinal: Nausea, vomiting, constipation, and abdominal pain. Cardiac: Arrhythmias.
Systemic: Fatigue, muscle weakness, headache, lethargy, and mental disturbances. Neurological: Coma.
Renal: Polydipsia, polyuria, and renal calcinosis. Organ Damage: Irreversible kidney and soft tissue calcification.

Official Emergency Response

Immediate medical attention must be sought for any suspected or confirmed overdose due to the potential for severe or irreversible outcomes. Regulatory instructions require the immediate and complete cessation of D3Up and all concurrent calcium supplements. No specific antidote is known, and official management relies on supportive procedures to address the hypercalcaemia. These documented measures include rehydration (IV or oral fluids) and specific pharmacological interventions such as loop diuretics or bisphosphonates for severe cases. Intensive monitoring of serum electrolytes, renal function, and cardiac activity (ECG) is required during management.

Therapeutic Uses of D3Up

What D3Up Treats: Main Uses and Benefits

D3Up (cholecalciferol) plays a role in supporting skeletal health and is relevant for addressing symptoms linked to bone- and muscle-related functional stress.


D3Up is generally used in situations involving certain distressing symptoms across conditions characterized by episodic or fluctuating manifestations. It is commonly applied in scenarios where short-term symptomatic assistance is needed to help manage discomfort; it contributes to easing distress, supports functional stability, and addresses related symptoms that interfere with daily comfort. This is relevant in situations requiring temporary assistance in symptom stabilization.

“The supplement supports the patient during difficult episodes by easing distress.”

Quick Fact: Relief for Temporary Functional Strain

The medicine helps support a sense of functional stability during phases where the patient experiences heightened discomfort, offering symptomatic relief when symptoms lead to temporary functional strain. It contributes to improved day-to-day comfort during symptomatic periods.

Eligibility and Restrictions for Use

Who Can and Cannot Use D3Up?

Eligibility for D3Up (alendronate/cholecalciferol) is strictly defined by regulatory health authorities and is based on a patient's pre-existing health conditions and physical capabilities. The medicine is intended for use in adults for approved indications, such as treating osteoporosis.


Contraindications (Must Not Use)

The official labeling specifies that D3Up must not be used by individuals with certain conditions:

  • Hypocalcemia: Patients with low calcium levels in the blood must have this condition corrected before beginning therapy.
  • Esophageal Abnormalities: Patients with conditions that delay esophageal emptying, such as stricture or achalasia, are ineligible.
  • Postural Restriction: Patients who are unable to stand or sit fully upright for a minimum of 30 minutes after taking the tablet must not use this medication.
  • Hypersensitivity: Individuals with a known allergy to any component of the medicine.

Restricted or Not Recommended Use

Certain populations are advised against using the product:

  • Severe Renal Impairment: Use is not recommended in patients with severely reduced kidney function (creatinine clearance <35 mL/min) due to lack of clinical experience.
  • Pediatric Patients: The medicine is not indicated for use in children under 18 years of age, as safety and efficacy have not been established in this age group.
  • Pregnancy and Lactation: As this product is generally intended for postmenopausal women, it is not intended for use in women who are pregnant or breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Colecalciferol (D3Up) documents interaction patterns primarily related to drug metabolism and effects on mineral balance.

Interactions Affecting D3Up Exposure

Mechanism / Class Example Agents Outcome on Colecalciferol
Metabolic Acceleration Phenytoin, Carbamazepine, Rifampin Increased catabolism (breakdown) via hepatic enzyme induction, leading to reduced plasma concentrations of Colecalciferol.
Absorption Interference Cholestyramine, Mineral Oil, Orlistat Interference with the intestinal uptake of the fat-soluble Colecalciferol, resulting in reduced serum concentration.

Timing-based constraints exist for substances that interfere with absorption, such as bile acid sequestrants and mineral oil. These substances must be administered with a required time separation from Colecalciferol to ensure adequate absorption.

Pharmacodynamic Interactions

Mechanism / Class Example Agents Interaction Outcome
Additive Hypercalcaemia Risk Thiazide Diuretics, Calcium Supplements Additive effects on calcium regulation, significantly increasing the risk of hypercalcaemia (high calcium levels).
Potentiation of Toxicity Cardiac Glycosides (e.g., Digoxin) Hypercalcaemia resulting from D3Up therapy potentiates the toxicity of cardiac glycosides, raising the risk of arrhythmias.

Corticosteroids may also reduce the effect of Colecalciferol by interfering with calcium absorption. The risk of hypercalcaemia from pharmacodynamic interactions is noted to be greater in patients with renal impairment, a population-specific caution documented in regulatory sources.

Mechanism of Action

How D3Up Works

D3Up is a pro-hormone delivery system that provides a calcifediol analog, bypassing the liver's 25-hydroxylation step. This analog is rapidly converted in the kidney into the biologically active form, calcitriol (1,25-dihydroxyvitamin D), via the enzyme 1alpha-hydroxylase.

The calcitriol compound acts as a high-affinity ligand for the Vitamin D Receptor (VDR), a nuclear transcription factor. VDR activation facilitates the intestinal absorption of calcium by upregulating the transient receptor potential cation channel, subfamily V, member 6 (TRPV6) protein.

This metabolic action influences the systemic calcium-phosphate homeostasis, which regulates the activity of bone-remodeling cells (osteoblasts and osteoclasts) and modulates calcium transport in muscle cells. The active metabolite increases circulating 1,25-dihydroxyvitamin D levels, leading to subsequent modulation of the calcium-sensing receptor (CaSR) pathway and modulating the expression of genes involved in cellular integrity and differentiation, concluding in the downstream upregulation of the VDR-mediated genomic effects.

Dosage and Administration Information

D3Up is administered solely via the oral route, with instructions defining distinct treatment and maintenance phases. The use of the medicine is categorized into two main patterns: a short-term, intermittent phase and a continuous, long-term phase.

Dosing Regimens and Frequency

The high-dose treatment phase often utilizes an intermittent schedule, such as taking 50,000 International Units (IU) once weekly for a specified number of weeks. Following this initial regimen, the use transitions into a continuous support pattern. The long-term maintenance phase generally requires a much lower, daily dose, typically ranging between 1,000 IU and 4,000 IU.

Administration Context and Procedural Rules

All forms of D3Up must be taken with food, optimally accompanying the main meal of the day. This instruction is necessary for the proper absorption of the fat-soluble active ingredient. For solid forms, such as the tablets or softgel capsules, the unit must be swallowed whole and cannot be crushed, chewed, or dissolved. Liquid preparations, including the oral solution, require the use of a calibrated measuring device to ensure the precise dose is delivered.

Usage is subject to specific considerations for certain patient groups. For instance, in individuals with severe renal impairment, D3Up is generally not the appropriate form of Vitamin D, as its metabolic activation pathway is compromised. If a dose is missed, patients are instructed to take the next scheduled dose without doubling the amount.

Recent Clinical Evidence

Research evidence / Overview of Studies for D3Up

Evidence Summary for Correcting Vitamin D Status

D3Up (Colecalciferol) was studied in clinical situations related to Vitamin D status, specifically deficiency or insufficiency. The research exploring this aspect primarily involved Randomized Controlled Trials (RCTs) and systematic reviews. The primary measurement used was the level of 25-hydroxyvitamin D [25( OH)D] in the blood. Research so far describes patterns where administering Colecalciferol was associated with a change in serum 25( OH)D levels, moving them toward certain established thresholds. This research provides context but does not determine whether an individual will respond similarly.

What remains uncertain is the optimal definition of Vitamin D sufficiency, as different health authorities use varying target levels. Furthermore, while the short-term observation of affecting blood levels is consistently reported, data detailing the long-term status of these corrected levels without continued administration are not comprehensively characterized.


Evidence Summary for Skeletal Health and Osteoporosis Support

D3Up was evaluated in long-term clinical trials focusing on skeletal health, often in older adults identified as at risk for skeletal events in the research. These trials frequently used Colecalciferol as an adjunct alongside calcium supplementation. Researchers examined outcomes related to functional activity level, specifically the rate of fractures and changes in Bone Mineral Density (BMD). Findings describe patterns observed in the studies where, particularly in high-risk groups, the combination of Colecalciferol and calcium was associated with patterns of fracture rate observations during the study period. Research exploring this in the general population of older, non-deficient adults has yielded mixed findings.

Evidence quality varies across studies. A key research limitation is the frequent co-administration of Colecalciferol with calcium, which makes it difficult to isolate the contribution of Colecalciferol alone to skeletal outcomes. Also, results apply only to the populations studied, and findings were often less certain when analyzing groups who were not initially Vitamin D deficient.


Research Landscape for Rickets and Osteomalacia

Research describing D3Up was studied in contexts involving rickets (in children) and osteomalacia (in adults) and is long-established. Studies examined Colecalciferol’s role in outcomes related to physiological strain or stress, such as bone healing. The available research primarily consists of clinical intervention studies and case observations. Studies monitored outcomes using radiographic evidence and the normalization of chemical markers related to bone metabolism. Research highlights changes measured during the study period, documenting that the symptomatic skeletal manifestations evolved concurrently with the correction of the deficiency.

Key Studies & References

  1. No evidence vitamin D supplements improve bone health, major analysis finds (2018 Meta-analysis summary on fractures and BMD)
  2. Draft Recommendation: Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Falls and Fractures in Community-Dwelling Adults (USPSTF)

Frequently Asked Questions (FAQ)

Common questions about D3Up (FAQ)


Q: Is D3Up the same as regular vitamin D supplements?

A: D3Up is the pharmaceutical preparation of Colecalciferol (Vitamin D3). While Colecalciferol is the same active substance found in many supplements, D3Up often refers to higher-strength doses that require a prescription. Official documents note that licensed medicine preparations are subject to specific regulatory quality standards for dosing and purity.


Q: Why do doctors prescribe D3Up instead of just buying it over the counter?

A: D3Up is categorized as a high-strength pharmaceutical preparation of Colecalciferol used in situations defined by regulatory guidelines. Official drug preparations are required to meet regulatory quality standards for purity and consistent dosing, which licensed health authorities emphasize over non-pharmaceutical supplements.


Q: How long does it usually take to feel or see the effects of D3Up?

A: Studies and official information indicate that D3Up begins to change the measurable blood levels of 25-hydroxyvitamin D within 2 to 4 weeks after starting treatment. Achieving certain measurable levels in the blood, as described in studies, may require several months of therapy.


Q: What should I do if I forget to take D3Up for a day?

A: Official patient instructions advise that if a dose is missed, the next scheduled dose should be taken at the usual time. It is specified in patient-facing information that the dose should not be doubled to make up for the one that was missed.


Q: What kind of studies have been done on the long-term use of D3Up?

A: Official clinical trials for D3Up (Colecalciferol) have included long-term observation studies. This research primarily focused on examining its role in maintaining Vitamin D status and its use as an adjunct therapy for conditions affecting skeletal health, such as osteoporosis, often alongside calcium.


Q: Why is D3Up sometimes described as a 'pro-drug'?

A: D3Up (Colecalciferol) is officially defined as a secosteroid pro-hormone. It is described this way because the body must metabolically convert it, primarily through the liver and kidneys, into the biologically active compound known as calcitriol.


Q: What are the possible signs of taking too much D3Up?

A: Taking too much D3Up over time can result in high calcium levels in the blood (hypercalcaemia). Symptoms associated with hypercalcaemia, as described in official documents, may include fatigue, increased thirst, more frequent urination, nausea, vomiting, or constipation.


Q: Why do official sources sometimes mention monitoring while using D3Up?

A: Official documents describe that levels of calcium in the blood and urine must be monitored during treatment. This monitoring is done to manage the risk of developing hypercalcaemia (high blood calcium) or hypercalciuria (high urine calcium), which are documented adverse reactions.


Q: What is the difference between D3Up and calcifediol?

A: D3Up (Colecalciferol) is the pro-hormone that is supplied. It is then converted by the liver into calcifediol (25-hydroxyvitamin D), which is considered the storage form of the vitamin. D3Up is the precursor, and calcifediol is its immediate major metabolite.


Q: What is the risk of having a serious side effect from D3Up?

A: The regulatory safety profile highlights the risk of Hypervitaminosis D (toxicity) if there is chronic excessive intake. The serious consequences of this state are primarily related to severe hypercalcaemia, which may potentially lead to irreversible renal insufficiency.


Q: Does D3Up have any effect on bone density?

A: Regulatory-cited clinical trials have investigated D3Up, often when combined with calcium, in contexts involving skeletal health. Researchers have specifically examined outcomes related to changes in Bone Mineral Density (BMD).


Q: Does D3Up contain ingredients other than the main drug?

A: Yes, pharmaceutical preparations of Colecalciferol contain the active ingredient and several inactive ingredients (excipients) necessary to create the final product, such as a lipid-based carrier for its fat-soluble nature.


Q: Is D3Up meant to be taken for a long time or just short-term?

A: Official documents describe D3Up use as generally involving two distinct patterns. These are an initial short-term, high-dose treatment phase and a subsequent continuous, lower-dose maintenance phase of use.


Q: Is it normal to feel tired when first starting D3Up?

A: While tiredness is not listed as a common side effect in official documents, these sources note that symptoms like drowsiness or fatigue can be a sign of Hypervitaminosis D (toxicity) resulting from high calcium levels.


Q: Where can I find the official regulatory document (like the FDA label) for D3Up?

A: Official regulatory documents, such as the Summary of Product Characteristics (SmPC) in Europe or the DailyMed/FDA Label in the US, are published online by the relevant governmental health authorities.


Q: Does D3Up have a generic or cheaper version available?

A: D3Up contains the active substance Colecalciferol, which is the same chemical entity found in generic versions of the drug. The availability of generic alternatives is determined by the drug's market authorization status.


Q: Does taking D3Up affect how other vitamins or minerals are absorbed?

A: The primary official mechanism of action focuses on D3Up's role in regulating the absorption of calcium and phosphorus. Regulatory documents do not broadly detail effects on the absorption of other specific vitamins or minerals.


Q: Is D3Up known to cause headaches?

A: Headache is not listed as a frequent adverse reaction. However, regulatory documents for high-dose Colecalciferol preparations sometimes mention headache as a possible symptom associated with hypercalcaemia from excessive intake.


Q: Can D3Up make you gain or lose weight?

A: Regulatory sources do not list weight change as a common side effect. However, weight loss and loss of appetite are noted as possible symptoms of Hypervitaminosis D (toxicity) resulting from high calcium levels.


Q: Do any ingredients in D3Up commonly cause allergic reactions?

A: D3Up is contraindicated for individuals with a known hypersensitivity to the active substance or any of the inactive ingredients. Rare adverse reactions have included skin reactions such as rash, pruritus (itching), or urticaria (hives).


Q: How does D3Up differ from Vitamin D2?

A: D3Up contains Colecalciferol (Vitamin D3), while Vitamin D2 is Ergocalciferol. Studies have described patterns where Vitamin D3 may show a greater ability than Vitamin D2 at elevating and maintaining the measurable blood levels of 25-hydroxyvitamin D.


Q: Will D3Up show up on any standard lab tests?

A: Yes, D3Up is a form of Vitamin D3 and is measured in the blood test for 25-hydroxyvitamin D [25(OH)D]. This test is the standard lab marker used for assessing the body's Vitamin D status.


Q: Does D3Up have an expiration date, and is it still good after that?

A: Yes, D3Up has an expiration date printed on the packaging as required by regulators. Official instructions advise against using the medicine after this date and direct that unused or expired product be disposed of according to local requirements.


Q: Is there a list of inactive ingredients in D3Up that I should be aware of?

A: Yes, the official labeling includes a list of all inactive ingredients (excipients). This list is provided for patient awareness, particularly for individuals with known sensitivities or allergies to specific components.


Q: Are there specific patient groups that benefit most from D3Up?

A: Official documentation indicates D3Up is used for patients with confirmed Vitamin D deficiency or insufficiency. Clinical trials for D3Up often include patient groups considered at risk for skeletal issues or those with limited sun exposure.


Q: What is the evidence regarding D3Up's use in people with specific chronic conditions?

A: Regulatory documents refer to special caution for use in certain chronic conditions, such as renal impairment or sarcoidosis. Official sources may note that special caution or alternative treatment approaches may be necessary for these patient groups.

How should D3Up be stored and disposed of?

The storage and disposal of D3Up (Colecalciferol) must adhere strictly to the conditions specified in official regulatory labeling to maintain product stability and ensure safety.

Storage Requirements

Official documents mandate storage at controlled room temperature, typically defined as 20 C to 25 C (68 F to 77 F), with permitted temperature excursions. The medicine must be protected from moisture and kept in its original container or packaging until use to maintain stability.

For safety, D3Up must be stored out of the sight and reach of children.

Disposal Instructions

All unused or expired product must be disposed of in accordance with local requirements. Official instructions advise against disposing of the medicine via wastewater or household waste to protect the environment from the active pharmaceutical ingredient.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of D3Up found in:

A-Z Index: